Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Bariatric Stretchers Market 2020 By Manufacturers, Regions, Type And Application, Forecast To 2026

  • Purchase Options

 

Summary

The global Bariatric Stretchers Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

Bariatric stretchers are used to help people with obesity. These are being used in hospitals where patients who have obesity or diabetes cannot eat on their own. These stilts are being used to help people who have to go through surgery or are recovering from surgery. Moreover, these are also used to assist patients who are having difficulty getting around. These strollers are designed to assist a patient who is overweight by carrying the patient and their bags while using a wheelchair. These come in various forms such as the pushchair, slings, walkers, and joggers. They are classified into fixed stretchers, adjustable stretchers, and stretcher chairs.

The growing obese population coupled with the increasing surgical procedure such as stomach reduction and gastric bypass is driving the market growth of bariatric stretchers. According to the World Health Organization, in 2019, an estimated 38.2 million children under the age of 5 years were overweight or obese. Overweight and obesity are now on the rise in low- and middle-income countries, particularly in urban areas. Moreover, growing cases of chronic disease due to a sedentary lifestyle is again driving the need for bariatric stretchers. Furthermore, technological advancement in the stretchers is further expected to augment the market growth of the bariatric stretchers.  

Additionally, growing global health care spending in order to improve the medical facilities is projected to uplift the market growth of the bariatric stretchers in the near future.

From the geographical point of view, North America is expected to gain significant growth and this is attributed to the increasing obese population coupled with the growing prevalence of chronic disease in the region. According to the Centers for Disease Control and Prevention, in 2017–2018, the age-adjusted prevalence of obesity in adults was 42.4%, and there were no significant differences between men and women among all adults or by age group. The prevalence was 40.0% among younger adults aged 20–39, 44.8% among middle-aged adults aged 40–59, and 42.8% among older adults aged 60 and over.

Key Developments:

In August 2020, Bedfordshire Fire and Rescue Service (BFRS) launched a new Technical Support Unit. Based at Dunstable Fire Station, it is the first of its kind in the country. This new vehicle will respond to Bariatric and complex patient incidents where emergency removal of a patient is required. The dedicated vehicle carries specialist equipment including a bariatric stretcher provided by EEAST.

The Bariatric Stretchers Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Bariatric Stretchers Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Ferno
  • Stryker
  • Hill-Rom
  • GIVAS
  • Byron
  • Getinge
  • Junkin Safety
  • MeBer
  • Fu Shun Hsing Technology
  • Sidhil
  • GF Health Products
  • PVS SpA
  • Pelican Manufacturing
  • BE SAFE
  • BESCO
  • Medline

By the Product Type, the market is primarily segmented into:

  • Fixed Stretchers
  • Adjustable Stretchers
  • Stretcher Chairs

By Applications, the market is segmented into:

  • Hospital
  • Clinic and Ambulance Facilities

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Bariatric Stretchers Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Bariatric Stretchers Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Bariatric Stretchers Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Bariatric Stretchers Market

The Bariatric Stretchers Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Bariatric Stretchers Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Executive Summary
1 Industry Overview of Spinal Muscular Atrophy Medicine
1.1 Definition of Spinal Muscular Atrophy Medicine
1.2 Spinal Muscular Atrophy Medicine Segment by Type
1.2.1 Global Spinal Muscular Atrophy Medicine Production Growth Rate Comparison by Types (2014-2025)
1.2.2 LMI-070
1.2.3 ND-602
1.2.4 NT-1654
1.2.5 Nusinersen
1.2.6 NXD-30001
1.2.7 Others
1.3 Spinal Muscular Atrophy Medicine Segment by Applications
1.3.1 Global Spinal Muscular Atrophy Medicine Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Spinal Muscular Atrophy Medicine Overall Market
1.4.1 Global Spinal Muscular Atrophy Medicine Revenue (2014-2025)
1.4.2 Global Spinal Muscular Atrophy Medicine Production (2014-2025)
1.4.3 North America Spinal Muscular Atrophy Medicine Status and Prospect (2014-2025)
1.4.4 Europe Spinal Muscular Atrophy Medicine Status and Prospect (2014-2025)
1.4.5 China Spinal Muscular Atrophy Medicine Status and Prospect (2014-2025)
1.4.6 Japan Spinal Muscular Atrophy Medicine Status and Prospect (2014-2025)
1.4.7 Southeast Asia Spinal Muscular Atrophy Medicine Status and Prospect (2014-2025)
1.4.8 India Spinal Muscular Atrophy Medicine Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Spinal Muscular Atrophy Medicine
2.3 Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine
2.4 Industry Chain Structure of Spinal Muscular Atrophy Medicine

3 Development and Manufacturing Plants Analysis of Spinal Muscular Atrophy Medicine
3.1 Capacity and Commercial Production Date
3.2 Global Spinal Muscular Atrophy Medicine Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Spinal Muscular Atrophy Medicine
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Spinal Muscular Atrophy Medicine Production and Capacity Analysis
4.2 Spinal Muscular Atrophy Medicine Revenue Analysis
4.3 Spinal Muscular Atrophy Medicine Price Analysis
4.4 Market Concentration Degree

5 Spinal Muscular Atrophy Medicine Regional Market Analysis
5.1 Spinal Muscular Atrophy Medicine Production by Regions
5.1.1 Global Spinal Muscular Atrophy Medicine Production by Regions
5.1.2 Global Spinal Muscular Atrophy Medicine Revenue by Regions
5.2 Spinal Muscular Atrophy Medicine Consumption by Regions
5.3 North America Spinal Muscular Atrophy Medicine Market Analysis
5.3.1 North America Spinal Muscular Atrophy Medicine Production
5.3.2 North America Spinal Muscular Atrophy Medicine Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Spinal Muscular Atrophy Medicine Import and Export
5.4 Europe Spinal Muscular Atrophy Medicine Market Analysis
5.4.1 Europe Spinal Muscular Atrophy Medicine Production
5.4.2 Europe Spinal Muscular Atrophy Medicine Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Spinal Muscular Atrophy Medicine Import and Export
5.5 China Spinal Muscular Atrophy Medicine Market Analysis
5.5.1 China Spinal Muscular Atrophy Medicine Production
5.5.2 China Spinal Muscular Atrophy Medicine Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Spinal Muscular Atrophy Medicine Import and Export
5.6 Japan Spinal Muscular Atrophy Medicine Market Analysis
5.6.1 Japan Spinal Muscular Atrophy Medicine Production
5.6.2 Japan Spinal Muscular Atrophy Medicine Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Spinal Muscular Atrophy Medicine Import and Export
5.7 Southeast Asia Spinal Muscular Atrophy Medicine Market Analysis
5.7.1 Southeast Asia Spinal Muscular Atrophy Medicine Production
5.7.2 Southeast Asia Spinal Muscular Atrophy Medicine Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Spinal Muscular Atrophy Medicine Import and Export
5.8 India Spinal Muscular Atrophy Medicine Market Analysis
5.8.1 India Spinal Muscular Atrophy Medicine Production
5.8.2 India Spinal Muscular Atrophy Medicine Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Spinal Muscular Atrophy Medicine Import and Export

6 Spinal Muscular Atrophy Medicine Segment Market Analysis (by Type)
6.1 Global Spinal Muscular Atrophy Medicine Production by Type
6.2 Global Spinal Muscular Atrophy Medicine Revenue by Type
6.3 Spinal Muscular Atrophy Medicine Price by Type

7 Spinal Muscular Atrophy Medicine Segment Market Analysis (by Application)
7.1 Global Spinal Muscular Atrophy Medicine Consumption by Application
7.2 Global Spinal Muscular Atrophy Medicine Consumption Market Share by Application (2014-2019)

8 Spinal Muscular Atrophy Medicine Major Manufacturers Analysis
8.1 Astellas Pharma Inc.
8.1.1 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
8.1.2 Astellas Pharma Inc. Product Introduction, Application and Specification
8.1.3 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 AveXis, Inc.
8.2.1 AveXis, Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
8.2.2 AveXis, Inc. Product Introduction, Application and Specification
8.2.3 AveXis, Inc. Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bioblast Pharma Ltd.
8.3.1 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production Sites and Area Served
8.3.2 Bioblast Pharma Ltd. Product Introduction, Application and Specification
8.3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cytokinetics, Inc. 24
8.4.1 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production Sites and Area Served
8.4.2 Cytokinetics, Inc. 24 Product Introduction, Application and Specification
8.4.3 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production Sites and Area Served
8.5.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
8.5.3 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Genethon
8.6.1 Genethon Spinal Muscular Atrophy Medicine Production Sites and Area Served
8.6.2 Genethon Product Introduction, Application and Specification
8.6.3 Genethon Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Genzyme Corporation
8.7.1 Genzyme Corporation Spinal Muscular Atrophy Medicine Production Sites and Area Served
8.7.2 Genzyme Corporation Product Introduction, Application and Specification
8.7.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 GMP-Orphan SAS
8.8.1 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production Sites and Area Served
8.8.2 GMP-Orphan SAS Product Introduction, Application and Specification
8.8.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Ionis Pharmaceuticals, Inc.
8.9.1 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
8.9.2 Ionis Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.9.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Longevity Biotech, Inc
8.10.1 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production Sites and Area Served
8.10.2 Longevity Biotech, Inc Product Introduction, Application and Specification
8.10.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Neurodyn Inc.
8.12 Neurotune AG
8.13 Novartis AG
8.14 Sarepta Therapeutics, Inc.
8.15 Voyager Therapeutics, Inc.
8.16 Vybion, Inc.
8.17 WAVE Life Sciences Ltd.

9 Development Trend of Analysis of Spinal Muscular Atrophy Medicine Market
9.1 Global Spinal Muscular Atrophy Medicine Market Trend Analysis
9.1.1 Global Spinal Muscular Atrophy Medicine Market Size (Volume and Value) Forecast 2019-2025
9.2 Spinal Muscular Atrophy Medicine Regional Market Trend
9.2.1 North America Spinal Muscular Atrophy Medicine Forecast 2019-2025
9.2.2 Europe Spinal Muscular Atrophy Medicine Forecast 2019-2025
9.2.3 China Spinal Muscular Atrophy Medicine Forecast 2019-2025
9.2.4 Japan Spinal Muscular Atrophy Medicine Forecast 2019-2025
9.2.5 Southeast Asia Spinal Muscular Atrophy Medicine Forecast 2019-2025
9.2.6 India Spinal Muscular Atrophy Medicine Forecast 2019-2025
9.3 Spinal Muscular Atrophy Medicine Market Trend (Product Type)
9.4 Spinal Muscular Atrophy Medicine Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Spinal Muscular Atrophy Medicine Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table
List of Tables and Figures
Figure Picture of Spinal Muscular Atrophy Medicine
Table Global Spinal Muscular Atrophy Medicine Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Spinal Muscular Atrophy Medicine Production Market Share by Types in 2018
Figure LMI-070 Product Picture
Figure ND-602 Product Picture
Figure NT-1654 Product Picture
Figure Nusinersen Product Picture
Figure NXD-30001 Product Picture
Figure Others Product Picture
Table Global Spinal Muscular Atrophy Medicine Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Spinal Muscular Atrophy Medicine Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Spinal Muscular Atrophy Medicine Revenue (Million USD) (2014-2025)
Figure Global Spinal Muscular Atrophy Medicine Production (K Pcs) (2014-2025)
Figure North America Spinal Muscular Atrophy Medicine Market Size (Million USD) (2014-2025)
Figure Europe Spinal Muscular Atrophy Medicine Market Size (Million USD) (2014-2025)
Figure China Spinal Muscular Atrophy Medicine Market Size (Million USD) (2014-2025)
Figure Japan Spinal Muscular Atrophy Medicine Market Size (Million USD) (2014-2025)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Market Size (Million USD) (2014-2025)
Figure India Spinal Muscular Atrophy Medicine Market Size (Million USD) (2014-2025)
Table Spinal Muscular Atrophy Medicine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Spinal Muscular Atrophy Medicine in 2018
Figure Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine
Figure Industry Chain Structure of Spinal Muscular Atrophy Medicine
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Spinal Muscular Atrophy Medicine Manufacturing Plants Distribution
Table Spinal Muscular Atrophy Medicine Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Spinal Muscular Atrophy Medicine Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Spinal Muscular Atrophy Medicine Production (K Pcs) of Major Manufacturers (2014-2019)
Table Spinal Muscular Atrophy Medicine Production Market Share of Major Manufacturers (2014-2019)
Figure Spinal Muscular Atrophy Medicine Production Share by Manufacturers in 2018
Table Spinal Muscular Atrophy Medicine Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Spinal Muscular Atrophy Medicine Revenue Market Share of Major Manufacturers (2014-2019)
Figure Spinal Muscular Atrophy Medicine Revenue Share by Manufacturers in 2018
Table Spinal Muscular Atrophy Medicine Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Spinal Muscular Atrophy Medicine Production by Regions 2014-2019 (K Pcs)
Table Global Spinal Muscular Atrophy Medicine Production Market Share by Regions 2014-2019
Figure Global Spinal Muscular Atrophy Medicine Production Market Share by Regions in 2018
Table Global Spinal Muscular Atrophy Medicine Revenue by Regions 2014-2019 (Million USD)
Table Global Spinal Muscular Atrophy Medicine Revenue Market Share by Regions 2014-2019
Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share by Regions in 2018
Table Global Spinal Muscular Atrophy Medicine Consumption by Regions 2014-2019 (K Pcs)
Table Global Spinal Muscular Atrophy Medicine Consumption Market Share by Regions 2014-2019
Figure North America Spinal Muscular Atrophy Medicine Production Growth Rate 2014-2019 (K Pcs)
Figure North America Spinal Muscular Atrophy Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table North America Spinal Muscular Atrophy Medicine Production, Consumption Import and Export (K Pcs)
Figure Europe Spinal Muscular Atrophy Medicine Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Spinal Muscular Atrophy Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Spinal Muscular Atrophy Medicine Production, Consumption Import and Export (K Pcs)
Figure China Spinal Muscular Atrophy Medicine Production Growth Rate 2014-2019 (K Pcs)
Figure China Spinal Muscular Atrophy Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table China Spinal Muscular Atrophy Medicine Production, Consumption Import and Export (K Pcs)
Figure Japan Spinal Muscular Atrophy Medicine Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Spinal Muscular Atrophy Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Spinal Muscular Atrophy Medicine Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Spinal Muscular Atrophy Medicine Production, Consumption Import and Export (K Pcs)
Figure India Spinal Muscular Atrophy Medicine Production Growth Rate 2014-2019 (K Pcs)
Figure India Spinal Muscular Atrophy Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table India Spinal Muscular Atrophy Medicine Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Spinal Muscular Atrophy Medicine Market Share by Application (2014-2019)
Figure Global Value (Consumption) Spinal Muscular Atrophy Medicine Market Share by Application (2014-2019)
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Product Introduction, Application and Specification
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production Growth Rate (2014-2019)
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production Market Share (2014-2019)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Revenue Market Share (2014-2019)
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Main Business and Markets Served
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Product Introduction, Application and Specification
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Production Growth Rate (2014-2019)
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Production Market Share (2014-2019)
Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Revenue Market Share (2014-2019)
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Main Business and Markets Served
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Product Introduction, Application and Specification
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production Growth Rate (2014-2019)
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production Market Share (2014-2019)
Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Revenue Market Share (2014-2019)
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Main Business and Markets Served
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Product Introduction, Application and Specification
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production Growth Rate (2014-2019)
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production Market Share (2014-2019)
Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Revenue Market Share (2014-2019)
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Main Business and Markets Served
Table Genethon Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table Genethon Spinal Muscular Atrophy Medicine Product Introduction, Application and Specification
Table Genethon Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genethon Spinal Muscular Atrophy Medicine Production Growth Rate (2014-2019)
Table Genethon Spinal Muscular Atrophy Medicine Production Market Share (2014-2019)
Figure Genethon Spinal Muscular Atrophy Medicine Revenue Market Share (2014-2019)
Table Genethon Spinal Muscular Atrophy Medicine Main Business and Markets Served
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Product Introduction, Application and Specification
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Production Growth Rate (2014-2019)
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Production Market Share (2014-2019)
Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Revenue Market Share (2014-2019)
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Main Business and Markets Served
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Product Introduction, Application and Specification
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production Growth Rate (2014-2019)
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production Market Share (2014-2019)
Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Revenue Market Share (2014-2019)
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Main Business and Markets Served
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Product Introduction, Application and Specification
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production Growth Rate (2014-2019)
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production Market Share (2014-2019)
Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Revenue Market Share (2014-2019)
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Main Business and Markets Served
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Product Introduction, Application and Specification
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production Growth Rate (2014-2019)
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production Market Share (2014-2019)
Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Revenue Market Share (2014-2019)
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Main Business and Markets Served
Table Neurodyn Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table Neurotune AG Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table Novartis AG Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table Vybion, Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
Table WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Production Sites and Area Served
Figure Global Spinal Muscular Atrophy Medicine Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Spinal Muscular Atrophy Medicine Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Spinal Muscular Atrophy Medicine Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Spinal Muscular Atrophy Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Spinal Muscular Atrophy Medicine Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Spinal Muscular Atrophy Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Spinal Muscular Atrophy Medicine Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Spinal Muscular Atrophy Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Spinal Muscular Atrophy Medicine Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Spinal Muscular Atrophy Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Spinal Muscular Atrophy Medicine Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Spinal Muscular Atrophy Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Spinal Muscular Atrophy Medicine by Type (2019-2025)
Table Global Consumption (K Pcs) of Spinal Muscular Atrophy Medicine by Application (2019-2025)
Table Spinal Muscular Atrophy Medicine Distributors List
Table Spinal Muscular Atrophy Medicine Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us